TRANSCATHETER AORTIC VALVE IMPLANTATION WITH USE OF BIVALIRUDIN IN PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA. CLINICAL CASE
- Authors: Komlev A.E.1, Romakina V.V.1, Imaev T.E.1, Kolegaev A.S.1, Akchurin R.S.1
-
Affiliations:
- National Medical Research Center of Cardiology
- Issue: Vol 22, No 1 (2020)
- Pages: 67-71
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95224
- DOI: https://doi.org/10.26442/20751753.2020.1.200017
- ID: 95224
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Aleksei E. Komlev
National Medical Research Center of Cardiologyкардиолог отд. сердечно-сосудистой хирургии Moscow, Russia
Valentina V. Romakina
National Medical Research Center of Cardiology
Email: dr513@mail.ru
кардиолог отд. сердечно-сосудистой хирургии Moscow, Russia
Timur E. Imaev
National Medical Research Center of Cardiologyд-р мед. наук, гл. науч. сотр. отд. сердечно-сосудистой хирургии Moscow, Russia
Aleksandr S. Kolegaev
National Medical Research Center of Cardiologyканд. мед. наук, науч. сотр. отд. сердечно-сосудистой хирургии Moscow, Russia
Renat S. Akchurin
National Medical Research Center of Cardiologyакад. РАН, д-р мед. наук, проф., рук. отд. сердечно-сосудистой хирургии Moscow, Russia
References
- Warkentin TE, Greinacher A. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not? Chest 2007; 132 (4): 1108-10. doi: 10.1378/chest.07-1553
- Datta I, Ball CG, Rudmik L et al. Complications related to deep venous thrombosis prophylaxis in trauma: a systematic review of the literature. J Trauma Manag Outcomes 2010; 4: 1. doi: 10.1186/1752-2897-4-1
- Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006; (8): 809-17. doi: 10.1056/NEJMcp052967
- Watson H, Davidson S, Keeling D. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. Br J Haematol 2012; 159: 528-40. doi: 10.1111/bjh.12059
- Seigerman M, Cavallaro P, Itagaki S et al. Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: An analysis of the nationwide inpatient sample. J Cardiothorac Vasc Anesth 2014; 28: 98-102. doi: 10.1053/j.jvca.2013.07.021
- Glance LG, Blumberg N, Eaton M et al. Preoperative thrombocytopenia and postoperative outcomes after noncardiac surgery. Anesthesiology 2014; 120 (1): 62-75. doi: 10.1097/ALN.0b013e3182a4441f
- Matthai WH. Thrombocytopenia in Cardiovascular Patients: diagnosis and Management. Chest 2005; 127 (Suppl. 2): 46S-52S. doi: 10.1378/chest.127.2_suppl.46S
- Васильев С.А., Горгидзе Л.А., Моисеева Т.Н. и др. Гепарининдуцированная тромбоцитопения (обзор). Атеротромбоз. 2019; 1: 99-114. doi: 10.21518/2307-1109-2019-1-99-114
- Марченко И.А., Шиян А.В., Андреева А.С. Современные методы лабораторной диагностики гепарин-индуцированной тромбоцитопении. Мед. совет. 2017; 12: 189-95.
- Семиголовский Н.Ю., Семиголовский С.Н. Патогенез, диагностика и лечение тромбоцитопений. Поликлиника.2015; 7: 20-5.
- Warkentin TE, Greinacher A, Koster A et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 340-80. doi: 10.1378/chest.08-0677
- Bleasel JF, Rasko JE, Rickard KA et al. Acute adrenal insufficiency secondary to heparin-induced thrombocytopenia-thrombosis syndrome. Med J Aust 1992; 157 (3): 192-3.
- Ivascu NS, Fitzgerald M, Ghadimi K et al. Heparin-induced thrombocytopenia: a review for cardiac anesthesiologists and intensivists. J Cardiothorac Vasc Anesth 2019; 33 (2): 511-20. doi: 10.1053/j.jvca.2018.10.035
- Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366 (18): 1686-95. doi: 10.1056/NEJMoa1200384
- Reardon MJ, Adams DH, Kleiman NS et al. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2015; 66 (2): 113-21. doi: 10.1016/j.jacc.2015.05.017
- Stone GW, Witzenbichler B, Guagliumi G et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358 (21): 2218-30. doi: 10.1056/NEJMoa0708191
- Stone GW, McLaurin BT, Cox DA et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355 (21): 2203-16. doi: 10.1056/NEJMoa062437
- Choxi AA, Patel PA, Augoustides JG et al. Bivalirudin for cardiopulmonary bypass in the setting of heparininduced thrombocytopeniya and combined yeart and ridney transplantation-diagnostic and therapeutic Challenges. J Cardiothorac Vasc Anesth 2017; 31 (1): 354-64. doi: 10.1053/j.jvca.2016.07.009
- Merry AF, Raudkivi PJ, Middleton NG et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77 (3): 925-31; discussion 931. doi: 10.1016/j.athoracsur.2003.09.061
- Smedira NG, Dyke CM, Koster A et al. Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study. J Thorac Cardiovasc Surg 2006; 131 (3): 686-92. doi: 10.1016/j.jtcvs.2005.10.049
- Dyke CM, Aldea G, Koster A et al. Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies. Ann Thorac Surg 2007; 84 (3): 836-9. doi: 10.1016/j.athoracsur.2007.04.007
- Kini A, Yu J, Cohen MG et al. Effect of bivalirudin on aortic valve intervention outcomes study: a two-center registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty. Euro Intervention 2014; 10 (3): 312-9. doi: 10.4244/EIJV10I3A54
- Lange P, Greif M, Bongiovanni D et al. Bivalirudin vs Heparin in Patients Who Undergo Transcatheter Aortic Valve Implantation. Can J Cardiol 2015; 31 (8): 998-1003. doi: 10.1016/j.cjca.2015.02.029
- Dangas GD, Lefevre T, Kupatt C et al. Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial. J Am Coll Cardiol 2015; 66 (25): 286068. doi: 10.1016/j.jacc.2015.10.003